{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:07:09Z","timestamp":1791378429236,"version":"4.3.2"},"reference-count":71,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Radiotherapy plays an important role in the treatment of esophageal cancer. Proton therapy has unique physical properties and higher relative biological effectiveness. However, whether proton therapy has greater benefit than photon therapy is still unclear.<\/jats:p><\/jats:sec>Objective<\/jats:title>To evaluate whether proton was associated with better efficacy and safety outcomes, including dosimetric, prognosis, and toxic effects outcomes, compared with photon therapy and to evaluate the efficacy and safety of proton therapy singly.<\/jats:p><\/jats:sec>Data Sources<\/jats:title>A systematic search of PubMed, Embase, the Cochrane Library, Web of Science, SinoMed, and China National Knowledge Infrastructure databases was conducted for articles published through November 25, 2021, and updated to March 25, 2023.<\/jats:p><\/jats:sec>Study Selection<\/jats:title>For the comparison of proton and photon therapy, studies including dosimetric, prognosis, and associated toxic effects outcomes were included. The separate evaluation of proton therapy evaluated the same metrics.<\/jats:p><\/jats:sec>Data Extraction and Synthesis<\/jats:title>Data on study design, individual characteristics, and outcomes were extracted. If I<\/jats:italic>2<\/jats:sup> was greater than 50%, the random-effects model was selected. This meta-analysis is reported following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA<\/jats:ext-link>) reporting guideline.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The main outcomes were organs at risk (OARs) dosimetric outcomes, prognosis (overall survival [OS], progression-free survival [PFS], and objective response rate [ORR]), and radiation-related toxic effects.<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 45 studies were included in the meta-analysis. For dosimetric analysis, proton therapy was associated with significantly reduced OARs dose. Meta-analysis showed that photon therapy was associated with poor OS (hazard ratio [HR], 1.31; 95% CI, 1.07-1.61; I<\/jats:italic>2<\/jats:sup>\u2009=\u200911%), but no difference in PFS was observed. Subgroup analysis showed worse OS (HR, 1.42; 95% CI, 1.14-1.78; I<\/jats:italic>2<\/jats:sup>\u2009=\u200934%) and PFS (HR, 1.48; 95% CI, 1.06-2.08; I<\/jats:italic>2<\/jats:sup>\u2009=\u20097%) in the radical therapy group with photon therapy. The pathological complete response rate was similar between groups. Proton therapy was associated with significantly decreased grade 2 or higher radiation pneumonitis and pericardial effusion, and grade 4 or higher lymphocytopenia. Single-rate analysis of proton therapy found 89% OS and 65% PFS at 1 year, 71% OS and 56% PFS at 2 years, 63% OS and 48% PFS at 3 years, and 56% OS and 42% PFS at 5 years. The incidence of grade 2 or higher radiation esophagitis was 50%, grade 2 or higher radiation pneumonitis was 2%, grade 2 or higher pleural effusion was 4%, grade 2 or higher pericardial effusion was 3%, grade 3 or higher radiation esophagitis was 8%, and grade 4 or higher lymphocytopenia was 17%.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this meta-analysis, proton therapy was associated with reduced OARs doses and toxic effects and improved prognosis compared with photon therapy for esophageal cancer, but caution is warranted. In the future, these findings should be further validated in randomized clinical trials.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.28136","type":"journal-article","created":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T15:20:20Z","timestamp":1692112820000},"page":"e2328136","source":"Crossref","is-referenced-by-count":37,"title":["Efficacy and Safety in Proton Therapy and Photon Therapy for Patients With Esophageal Cancer"],"prefix":"10.1001","volume":"6","author":[{"given":"Pixiao","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Oncology, Changde Hospital, Xiangya School of Medicine, Central South University, Changde, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangfeng","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Oncology, Changde Hospital, Xiangya School of Medicine, Central South University, Changde, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Second People\u2019s Hospital of Yibin, Yibin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Oncology, Changde Hospital, Xiangya School of Medicine, Central South University, Changde, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology, Changde Hospital, Xiangya School of Medicine, Central South University, Changde, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Oncology, Changde Hospital, Xiangya School of Medicine, Central South University, Changde, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Oncology, Changde Hospital, Xiangya School of Medicine, Central South University, Changde, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zemin","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Oncology, Changde Hospital, Xiangya School of Medicine, Central South University, Changde, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,8,15]]},"reference":[{"key":"zoi230808r1","doi-asserted-by":"publisher","first-page":"17048","DOI":"10.1038\/nrdp.2017.48","article-title":"Oesophageal cancer.","volume":"3","author":"Smyth","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"31","key":"zoi230808r2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007685","article-title":"Comparison of IMRT versus 3D-CRT in the treatment of esophagus cancer: A systematic review and meta-analysis.","volume":"96","author":"Xu","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"zoi230808r3","first-page":"641","article-title":"Chinese esophageal cancer radiotherapy guidelines (2020 version).","volume":"47","author":"Chinese Medical Doctors Association Division of Radiation Oncology Physicians","year":"2020","journal-title":"Guoji Zhongliuxue Zazhi"},{"issue":"1","key":"zoi230808r4","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.radonc.2012.09.003","article-title":"Proton therapy radiation pneumonitis local dose-response in esophagus cancer patients.","volume":"106","author":"Echeverria","year":"2013","journal-title":"Radiother Oncol"},{"issue":"18","key":"zoi230808r5","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1200\/JCO.2017.74.0720","article-title":"Bayesian adaptive randomization trial of passive scattering proton therapy and intensity-modulated photon radiotherapy for locally advanced non\u2013small-cell lung cancer.","volume":"36","author":"Liao","year":"2018","journal-title":"J Clin Oncol"},{"issue":"1","key":"zoi230808r6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ijrobp.2005.10.031","article-title":"High-dose proton beam therapy for stage I non\u2013small-cell lung cancer.","volume":"65","author":"Nihei","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"zoi230808r7","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1378\/chest.116.5.1313","article-title":"Proton-beam radiotherapy for early-stage lung cancer.","volume":"116","author":"Bush","year":"1999","journal-title":"Chest"},{"key":"zoi230808r8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range.","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"zoi230808r9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis.","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"key":"zoi230808r10","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.radonc.2021.01.014","article-title":"Towards the clinical implementation of intensity-modulated proton therapy for thoracic indications with moderate motion: robust optimised plan evaluation by means of patient and machine specific information.","volume":"157","author":"Ribeiro","year":"2021","journal-title":"Radiother Oncol"},{"issue":"3","key":"zoi230808r11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.meddos.2020.12.003","article-title":"Proton beam therapy can achieve lower vertebral bone marrow dose than photon beam therapy during chemoradiation therapy of esophageal cancer.","volume":"46","author":"Zhang","year":"2021","journal-title":"Med Dosim"},{"key":"zoi230808r12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.radonc.2020.07.015","article-title":"Weekly robustness evaluation of intensity-modulated proton therapy for oesophageal cancer.","volume":"151","author":"Anakotta","year":"2020","journal-title":"Radiother Oncol"},{"issue":"1","key":"zoi230808r13","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13014-020-01570-y","article-title":"Volumetric modulated arc therapy versus intensity-modulated proton therapy in neoadjuvant irradiation of locally advanced oesophageal cancer.","volume":"15","author":"Celik","year":"2020","journal-title":"Radiat Oncol"},{"issue":"7","key":"zoi230808r14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/acm2.2019.20.issue-7","article-title":"Dosimetric comparison of distal esophageal carcinoma plans for patients treated with small-spot intensity-modulated proton versus volumetric-modulated arc therapies.","volume":"20","author":"Liu","year":"2019","journal-title":"J Appl Clin Med Phys"},{"key":"zoi230808r15","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.radonc.2018.09.018","article-title":"Validation of a robust strategy for proton spot scanning for oesophageal cancer in the presence of anatomical changes.","volume":"131","author":"M\u00f8ller","year":"2019","journal-title":"Radiother Oncol"},{"issue":"1","key":"zoi230808r16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13014-018-0966-5","article-title":"Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinoma.","volume":"13","author":"Hirano","year":"2018","journal-title":"Radiat Oncol"},{"issue":"1","key":"zoi230808r17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.radonc.2017.07.034","article-title":"Dosimetric comparison to the heart and cardiac substructure in a large cohort of esophageal cancer patients treated with proton beam therapy or Intensity-modulated radiation therapy.","volume":"125","author":"Shiraishi","year":"2017","journal-title":"Radiother Oncol"},{"issue":"3","key":"zoi230808r18","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.ijrobp.2017.07.025","article-title":"Potential of proton therapy to reduce acute hematologic toxicity in concurrent chemoradiation therapy for esophageal cancer.","volume":"99","author":"Warren","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"zoi230808r19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ijrobp.2016.01.044","article-title":"An analysis of plan robustness for esophageal tumors: comparing volumetric modulated arc therapy plans and spot scanning proton planning.","volume":"95","author":"Warren","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"zoi230808r20","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.3390\/cancers6042356","article-title":"Analysis of intensity-modulated radiation therapy (IMRT), proton and 3D conformal radiotherapy (3D-CRT) for reducing perioperative cardiopulmonary complications in esophageal cancer patients.","volume":"6","author":"Ling","year":"2014","journal-title":"Cancers (Basel)"},{"issue":"5","key":"zoi230808r21","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/j.ijrobp.2010.07.2001","article-title":"Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study.","volume":"81","author":"Welsh","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"zoi230808r22","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ijrobp.2008.05.014","article-title":"Four-dimensional computed tomography-based treatment planning for intensity-modulated radiation therapy and proton therapy for distal esophageal cancer.","volume":"72","author":"Zhang","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"zoi230808r23","first-page":"226","article-title":"Dosimetric comparison between proton therapy and x-ray intensity-modulated radiotherapy for cervical esophageal cancer.","volume":"20","author":"Mu","year":"2011","journal-title":"Chin J Radiat Oncol"},{"issue":"4","key":"zoi230808r24","doi-asserted-by":"publisher","first-page":"866","DOI":"10.14338\/IJPT-14-00018.1","article-title":"Comparing proton beam to intensity modulated radiation therapy planning in esophageal cancer.","volume":"1","author":"Wang","year":"2015","journal-title":"Int J Part Ther"},{"key":"zoi230808r25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.699172","article-title":"Photon versus proton beam therapy for T1-3 squamous cell carcinoma of the thoracic esophagus without lymph node metastasis.","volume":"11","author":"Suh","year":"2021","journal-title":"Front Oncol"},{"issue":"2","key":"zoi230808r26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.14338\/IJPT-20-00086","article-title":"Radiation-induced lymphopenia risks of photon versus proton therapy for esophageal cancer patients.","volume":"8","author":"Ebrahimi","year":"2021","journal-title":"Int J Part Ther"},{"key":"zoi230808r27","doi-asserted-by":"publisher","DOI":"10.1093\/jrr\/rrab094","article-title":"The impact of lymphopenia during chemoradiotherapy using photons or protons on the clinical outcomes of esophageal cancer patients.","author":"Sumiya","year":"2021","journal-title":"J Radiat Res"},{"issue":"14","key":"zoi230808r28","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1200\/JCO.19.02503","article-title":"Randomized phase IIB trial of proton beam therapy versus intensity-modulated radiation therapy for locally advanced esophageal cancer.","volume":"38","author":"Lin","year":"2020","journal-title":"J Clin Oncol"},{"issue":"10","key":"zoi230808r29","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/j.jtho.2020.06.014","article-title":"Incidence and onset of severe cardiac events after radiotherapy for esophageal cancer.","volume":"15","author":"Wang","year":"2020","journal-title":"J Thorac Oncol"},{"issue":"4","key":"zoi230808r30","doi-asserted-by":"publisher","first-page":"663","DOI":"10.21037\/jgo","article-title":"Pathologic complete response (pCR) rates and outcomes after neoadjuvant chemoradiotherapy with proton or photon radiation for adenocarcinomas of the esophagus and gastroesophageal junction.","volume":"11","author":"DeCesaris","year":"2020","journal-title":"J Gastrointest Oncol"},{"issue":"5","key":"zoi230808r31","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.adro.2020.04.026","article-title":"Acute toxicities and short-term patient outcomes after intensity-modulated proton beam radiation therapy or intensity-modulated photon radiation therapy for esophageal carcinoma: a Mayo Clinic experience.","volume":"5","author":"Bhangoo","year":"2020","journal-title":"Adv Radiat Oncol"},{"issue":"1","key":"zoi230808r32","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.adro.2018.09.004","article-title":"A Comparison of grade 4 lymphopenia with proton versus photon radiation therapy for esophageal cancer.","volume":"4","author":"Routman","year":"2019","journal-title":"Adv Radiat Oncol"},{"issue":"1","key":"zoi230808r33","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.radonc.2017.11.028","article-title":"Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: a propensity matched analysis of the relative risk of proton versus photon-based radiation therapy.","volume":"128","author":"Shiraishi","year":"2018","journal-title":"Radiother Oncol"},{"issue":"3","key":"zoi230808r34","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.2378","article-title":"Heart dose and outcomes in radiation treatment for esophageal cancer.","volume":"10","author":"Macomber","year":"2018","journal-title":"Cureus"},{"issue":"3","key":"zoi230808r35","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.ijrobp.2017.06.2450","article-title":"Comparative outcomes after definitive chemoradiotherapy using proton beam therapy versus intensity modulated radiation therapy for esophageal cancer: a retrospective, single-institutional analysis.","volume":"99","author":"Xi","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"zoi230808r36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.14338\/IJPT-17-00033.1","article-title":"Lymphocyte-sparing effect of proton therapy in patients with esophageal cancer treated with definitive chemoradiation.","volume":"4","author":"Fang","year":"2018","journal-title":"Int J Part Ther"},{"issue":"3","key":"zoi230808r37","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.radonc.2017.04.013","article-title":"Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancer.","volume":"123","author":"Lin","year":"2017","journal-title":"Radiother Oncol"},{"issue":"3","key":"zoi230808r38","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1093\/jrr\/rrv001","article-title":"Comparison of adverse effects of proton and x-ray chemoradiotherapy for esophageal cancer using an adaptive dose-volume histogram analysis.","volume":"56","author":"Makishima","year":"2015","journal-title":"J Radiat Res"},{"issue":"5","key":"zoi230808r39","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2021.100751","article-title":"Dosimetry and acute toxicity profile of patients with esophageal cancer treated with proton beam radiation therapy: outcomes from the Proton Collaborative Group REG001-09 Trial.","volume":"6","author":"Parzen","year":"2021","journal-title":"Adv Radiat Oncol"},{"issue":"10","key":"zoi230808r40","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1007\/s10147-021-01981-1","article-title":"Retrospective analysis of neoadjuvant chemotherapy followed by surgery versus definitive chemoradiotherapy with proton beam for locally advanced esophageal squamous cell carcinoma.","volume":"26","author":"Ogawa","year":"2021","journal-title":"Int J Clin Oncol"},{"issue":"3","key":"zoi230808r41","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10388-020-00715-y","article-title":"Therapeutic results of proton beam therapy with concurrent chemotherapy for cT1 esophageal cancer and salvage endoscopic therapy for local recurrence.","volume":"17","author":"Sato","year":"2020","journal-title":"Esophagus"},{"issue":"3","key":"zoi230808r42","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.adro.2017.06.002","article-title":"Clinical outcomes of intensity modulated proton therapy and concurrent chemotherapy in esophageal carcinoma: a single institutional experience.","volume":"2","author":"Prayongrat","year":"2017","journal-title":"Adv Radiat Oncol"},{"issue":"12","key":"zoi230808r43","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s00066-016-1034-4","article-title":"Proton therapy posterior beam approach with pencil beam scanning for esophageal cancer: Clinical outcome, dosimetry, and feasibility.","volume":"192","author":"Zeng","year":"2016","journal-title":"Strahlenther Onkol"},{"issue":"3","key":"zoi230808r44","first-page":"1757","article-title":"Proton beam therapy combined with concurrent chemotherapy for esophageal cancer.","volume":"35","author":"Ishikawa","year":"2015","journal-title":"Anticancer Res"},{"issue":"3","key":"zoi230808r45","doi-asserted-by":"publisher","first-page":"e345","DOI":"10.1016\/j.ijrobp.2012.01.003","article-title":"Proton beam therapy and concurrent chemotherapy for esophageal cancer.","volume":"83","author":"Lin","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"zoi230808r46","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1200\/CCI.21.00098","article-title":"Identifying individualized risk profiles for radiotherapy-induced lymphopenia among patients with esophageal cancer using machine learning.","volume":"5","author":"Zhu","year":"2021","journal-title":"JCO Clin Cancer Inform"},{"key":"zoi230808r47","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.phro.2022.04.005","article-title":"Comparison of intensity modulated proton therapy beam configurations for treating thoracic esophageal cancer.","volume":"22","author":"Oonsiri","year":"2022","journal-title":"Phys Imaging Radiat Oncol"},{"issue":"1","key":"zoi230808r48","doi-asserted-by":"publisher","first-page":"18","DOI":"10.14338\/IJPT-22-00001.1","article-title":"Health care resource utilization for esophageal cancer using proton versus photon radiation therapy.","volume":"9","author":"Lin","year":"2022","journal-title":"Int J Part Ther"},{"issue":"8","key":"zoi230808r49","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.3390\/cancers14082033","article-title":"A comparative analysis of photon versus proton beam therapy in neoadjuvant concurrent chemoradiotherapy for intrathoracic squamous cell carcinoma of the esophagus at a single institute.","volume":"14","author":"Choi","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"3","key":"zoi230808r50","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.meddos.2022.02.009","article-title":"Dose-volume comparison of intensity modulated proton therapy and volumetric modulated arc therapy for cervical esophageal cancer.","volume":"47","author":"Kato","year":"2022","journal-title":"Med Dosim"},{"issue":"5","key":"zoi230808r51","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.4103\/jcrt.jcrt_382_22","article-title":"The feasibility of dose escalation using intensity-modulated radiotherapy (IMRT) and intensity-modulated proton therapy (IMPT) with FDG PET\/CT guided in esophageal cancer.","volume":"18","author":"Zhang","year":"2022","journal-title":"J Cancer Res Ther"},{"key":"zoi230808r52","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.954187","article-title":"Dosimetric analysis and biological evaluation between proton radiotherapy and photon radiotherapy for the long target of total esophageal squamous cell carcinoma.","volume":"12","author":"Cui","year":"2022","journal-title":"Front Oncol"},{"issue":"3","key":"zoi230808r53","doi-asserted-by":"publisher","first-page":"18","DOI":"10.14338\/IJPT-22-00021.1","article-title":"Proton therapy with concurrent chemotherapy for thoracic esophageal cancer: toxicity, disease control, and survival outcomes.","volume":"9","author":"Rutenberg","year":"2022","journal-title":"Int J Part Ther"},{"issue":"8","key":"zoi230808r54","doi-asserted-by":"publisher","first-page":"e339","DOI":"10.1016\/j.clon.2021.04.003","article-title":"The promise of proton beam therapy for oesophageal cancer: a systematic review of dosimetric and clinical outcomes.","volume":"33","author":"Nicholas","year":"2021","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"6","key":"zoi230808r55","first-page":"964","article-title":"Efficacy and safety of proton therapy and photon therapy for esophageal cancer: a meta-analysis.","volume":"38","author":"Zhu","year":"2022","journal-title":"J Mod Med Health"},{"issue":"6","key":"zoi230808r56","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.asjsur.2022.01.079","article-title":"The efficacy and safety of proton, carbon ion and TOMO radiotherapy for esophageal cancer: a systematic review and meta-analysis.","volume":"45","author":"Lin","year":"2022","journal-title":"Asian J Surg"},{"issue":"11","key":"zoi230808r57","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer.","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"key":"zoi230808r58","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.addr.2016.11.006","article-title":"Proton therapy\u2014present and future.","volume":"109","author":"Mohan","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"zoi230808r59","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jtho.2020.10.013","article-title":"Toxicity and survival after intensity-modulated proton therapy versus passive scattering proton therapy for NSCLC.","volume":"16","author":"Gjyshi","year":"2021","journal-title":"J Thorac Oncol"},{"key":"zoi230808r60","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ctro.2019.04.016","article-title":"Heart and lung doses are independent predictors of overall survival in esophageal cancer after chemoradiotherapy.","volume":"17","author":"Xu","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"key":"zoi230808r61","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.908345","article-title":"Functional lung imaging in thoracic tumor radiotherapy: application and progress.","volume":"12","author":"Zhou","year":"2022","journal-title":"Front Oncol"},{"issue":"4","key":"zoi230808r62","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.ijrobp.2021.10.147","article-title":"Results of a multi-institutional phase 2 clinical trial for 4DCT-ventilation functional avoidance thoracic radiation therapy.","volume":"112","author":"Vinogradskiy","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"zoi230808r63","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00066-022-02012-2","article-title":"4DCT ventilation function image-based functional lung protection for esophageal cancer radiotherapy.","volume":"199","author":"Zhou","year":"2023","journal-title":"Strahlenther Onkol"},{"issue":"3","key":"zoi230808r64","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s12194-020-00572-5","article-title":"The impact of 4DCT-ventilation imaging-guided proton therapy on stereotactic body radiotherapy for lung cancer.","volume":"13","author":"Ieko","year":"2020","journal-title":"Radiol Phys Technol"},{"issue":"1","key":"zoi230808r65","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.radonc.2014.11.037","article-title":"Is cardiac toxicity a relevant issue in the radiation treatment of esophageal cancer?","volume":"114","author":"Beukema","year":"2015","journal-title":"Radiother Oncol"},{"issue":"7","key":"zoi230808r66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158916","article-title":"Radiation therapy and cardiac death in long-term survivors of esophageal cancer: an analysis of the Surveillance, Epidemiology, and End Result Database.","volume":"11","author":"Gharzai","year":"2016","journal-title":"PLoS One"},{"key":"zoi230808r67","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.radonc.2021.10.015","article-title":"Pelvic bone marrow sparing radiotherapy for cervical cancer: a systematic review and meta-analysis.","volume":"165","author":"Zhou","year":"2021","journal-title":"Radiother Oncol"},{"issue":"1","key":"zoi230808r68","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ijrobp.2015.09.022","article-title":"Thoracic vertebral body irradiation contributes to acute hematologic toxicity during chemoradiation therapy for non\u2013small-cell lung cancer.","volume":"94","author":"Deek","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"zoi230808r69","doi-asserted-by":"publisher","first-page":"E206","DOI":"10.1016\/j.ijrobp.2019.06.2041","article-title":"Dose to heart, spine, aorta, and body predict for severe lymphopenia and poor survival in patients undergoing chemoradiation for esophageal cancer.","volume":"105","author":"Zhang","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"zoi230808r70","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ijrobp.2016.10.046","article-title":"Does unintentional splenic radiation predict outcomes after pancreatic cancer radiation therapy?","volume":"97","author":"Chadha","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"zoi230808r71","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ijrobp.2017.05.037","article-title":"Lymphocyte nadir and esophageal cancer survival outcomes after chemoradiation therapy.","volume":"99","author":"Davuluri","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2808359\/zhou_2023_oi_230808_1691425924.87837.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T15:20:28Z","timestamp":1692112828000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2808359"}},"subtitle":["A Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[2023,8,15]]},"references-count":71,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.28136","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,15]]}}}